Pharming Group NV (PHAR)
11.96
+0.50
(+4.36%)
USD |
NASDAQ |
Aug 25, 16:00
11.96
0.00 (0.00%)
After-Hours: 19:29
Pharming Group EPS Diluted (Quarterly) : 0.02 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.02 |
| March 31, 2026 | -0.0746 |
| December 31, 2025 | 0.0699 |
| September 30, 2025 | 0.109 |
| June 30, 2025 | 0.068 |
| March 31, 2025 | -0.2166 |
| December 31, 2024 | 0.054 |
| September 30, 2024 | -0.0152 |
| June 30, 2024 | -0.0177 |
| March 31, 2024 | -0.1851 |
| December 31, 2023 | -0.0405 |
| September 30, 2023 | 0.0525 |
| June 30, 2023 | 0.02 |
| March 31, 2023 | -0.1868 |
| December 31, 2022 | -0.2247 |
| September 30, 2022 | 0.1319 |
| June 30, 2022 | 0.2126 |
| March 31, 2022 | 0.0532 |
| December 31, 2021 | 0.0317 |
| September 30, 2021 | -0.0066 |
| June 30, 2021 | 0.0901 |
| March 31, 2021 | 0.1332 |
| December 31, 2020 | 0.1388 |
| September 30, 2020 | 0.1219 |
| June 30, 2020 | 0.1494 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1212 |
| December 31, 2019 | 0.1993 |
| September 30, 2019 | 0.1848 |
| June 30, 2019 | 0.117 |
| March 31, 2019 | 0.1135 |
| December 31, 2018 | 0.194 |
| September 30, 2018 | 0.1011 |
| June 30, 2018 | 0.058 |
| March 31, 2018 | 0.0983 |
| December 31, 2017 | -0.8595 |
| September 30, 2017 | -0.1762 |
| June 30, 2017 | -0.5617 |
| March 31, 2017 | -0.1279 |
| December 31, 2016 | -0.1832 |
| September 30, 2016 | -0.0997 |
| June 30, 2016 | -0.0897 |
| March 31, 2016 | -0.0875 |
| December 31, 2015 | -0.1086 |
| September 30, 2015 | -0.0662 |
| June 30, 2015 | -0.0549 |
| March 31, 2015 | -0.0335 |
| December 31, 2014 | 0.3967 |
| September 30, 2014 | 0.041 |
| June 30, 2014 | -0.1361 |
| March 31, 2014 | -0.544 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ProQR Therapeutics NV | -0.0923 |
| NewAmsterdam Pharma Co. NV | -0.5199 |
| argenx SE | -- |
| DBV Technologies SA | -0.5804 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.598M |
| Revenue (Quarterly) | 90.08M |
| Total Expenses (Quarterly) | 88.48M |
| Enterprise Value | 779.59M |
| Gross Profit Margin (Quarterly) | 80.56% |
| Profit Margin (Quarterly) | 1.77% |
| Earnings Yield | 1.04% |
| Operating Earnings Yield | 2.54% |
| Normalized Earnings Yield | 1.863 |